About this trial
As part of the clinical management of certain severe, drug-resistant forms of epilepsy, it is necessary to implant electrodes in the brain to identify the epileptic network prior to potential neurosurgical resection of the source zones. This standardized procedure, known as Stereo-Electroencephalography (SEEG), was developed in France in the 1960s. The electrodes remain implanted for several days-typically two weeks-while awaiting spontaneous epileptic seizures. During this period, the patient remains hospitalized, and their electroencephalographic activity is recorded around the clock.
Patients can be asked to perform cognitive tasks (such as tasks involving memory, attention, vision, language, and decision-making) while awake or asleep; the results can then be correlated with the intracerebral electroencephalographic activity recorded simultaneously as part of their clinical care. This approach makes it possible to capture the electrophysiological signatures of specific cognitive processes, thereby enabling researchers to: 1) create a brain map of electrophysiological signatures, 2) improve standard models of cognitive function, and 3) study the dysfunction of these processes in epilepsy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient with drug-resistant focal epilepsy undergoing SEEG evaluation as part of the pre-surgical workup for epilepsy
Intellectual capacity sufficient to perform cognitive tasks, receive information about the study procedure, and understand the information sheet
Disqualifiers
Patients already participating in another research project that prohibits participation in another study
Trial population
patients with drug-resistant epilepsy hospitalized for stereo-electroencephalography
Trial design
Cohort
Prospective
Treatments tested in this trial
Cognitive tasks in the form of questionnaires
Other interventionDuring their hospitalization for SEEG, patients will perform cognitive tasks to assess memory, vision, attention, language, and decision-making.
Treatment groups
Trial outcomes
Primary outcomes
Construction of a database of electrophysiological signatures of various cognitive functions
Correlation of performance on a task involving a neurocognitive process with characteristics of brain activity recorded during the task (electrophysiological signature) using intracranial stereo-electroencephalography (SEEG) electrodes.
Secondary outcomes
Evaluation of the impact of epilepsy on these electrophysiological signatures
Significant impact of the patient's epilepsy on the normal electrophysiological signature expected during certain cognitive processes.
Determine whether a given brain region is dysfunctional in certain epileptic patients by comparing it with the atlas of normal physiological signatures.
Identification of a dysfunctional brain region in an epileptic patient if the electrophysiological signature differs significantly from that expected based on the atlas.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: